Ragosa Mark bought KNSA
December 8, 2025 · Form 4 insider transaction
Ragosa Mark bought 10,512 shares of Kiniksa Pharmaceuticals International, plc at $10.76 per share, a transaction worth $113.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,512
Price
$10.76
Total value
$113.1K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after73,927
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.